NEW YORK, Sept. 26, 2022 /PRNewswire/ -- The "Alpha Glucosidase Inhibitors Market by Disease Type and Geography - Forecast and Analysis 2022-2026" report has been added to Technavio's offering. With ISO 9001:2015 certification, Technavio is proudly partnering with more than 100 Fortune 500 companies for over 16 years.
Read more at prnewswire.comPress Releases
Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.